Glucagonoma
Showing 1 - 25 of 30
DOTATOC PET/CT for Imaging NET Patients
Recruiting
- Neuroendocrine Tumors
- +15 more
- 68Ga-DOTATOC PET/CT
- 18F-FDG PET/CT
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 2, 2022
Pancreatic Tumor, Benign, Pancreatic Tumors, Pancreatic Adenocarcinoma Trial in Houston (Distal Pancreatectomy Sealing Using
Completed
- Pancreatic Tumor, Benign
- +13 more
- Distal Pancreatectomy Sealing Using LTW
-
Houston, TexasBaylor CHI St. Luke's Medical Center
Apr 4, 2022
Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)
Completed
- Gastrinoma
- +8 more
- regorafenib
- laboratory biomarker analysis
-
Scottsdale, Arizona
- +4 more
Nov 15, 2021
Gastrinoma, Glucagonoma, Insulinoma Trial in Stanford (Capecitabine, Temozolomide, Bevacizumab)
Completed
- Gastrinoma
- +8 more
- Capecitabine
- +2 more
-
Stanford, CaliforniaStanford University Medical Center
Apr 8, 2021
Gastrinoma, Glucagonoma, Insulinoma Trial in Boston (everolimus, )
Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in
Completed
- Gastrin-Producing Neuroendocrine Tumor
- +10 more
- Laboratory Biomarker Analysis
- +2 more
-
Boston, Massachusetts
- +2 more
Mar 25, 2020
Gastrinoma, Glucagonoma, Insulinoma Trial in United States (temozolomide, capecitabine, laboratory biomarker analysis)
Active, not recruiting
- Gastrinoma
- +6 more
-
Anaheim, California
- +322 more
Oct 14, 2022
Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,
Completed
- Adult Hepatocellular Carcinoma
- +44 more
- Bevacizumab
- Temsirolimus
-
Scottsdale, Arizona
- +60 more
Jan 24, 2019
Neuroendocrine Tumors Trial in Beijing (68Ga-DOTATATE)
Unknown status
- Neuroendocrine Tumors
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Jul 30, 2019
Gastrinoma, Glucagonoma, Insulinoma Trial (dovitinib lactate, pharmacological study, laboratory biomarker analysis)
Withdrawn
- Gastrinoma
- +5 more
- dovitinib lactate
- +2 more
- (no location specified)
Jul 18, 2017
Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Lung Cancer Trial in San Francisco, Vallejo (bevacizumab, 5-fluorouracil,
Terminated
- Gastrointestinal Carcinoid Tumor
- +4 more
- bevacizumab
- +3 more
-
San Francisco, California
- +1 more
Dec 12, 2019
Functional Pancreatic Neuroendocrine Tumor, Malignant Somatostatinoma, Merkel Cell Carcinoma Trial (Capecitabine, Temozolomide,
Withdrawn
- Functional Pancreatic Neuroendocrine Tumor
- +28 more
- Capecitabine
- +4 more
- (no location specified)
Sep 26, 2017
Pancreatic Cancer Trial in Minneapolis (Bortezomib, Panobinostat)
Terminated
- Pancreatic Cancer
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Dec 3, 2017
Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Metastatic Cancer Trial in Baltimore (PVA microporous
Terminated
- Gastrointestinal Carcinoid Tumor
- +2 more
- PVA microporous hydrospheres/doxorubicin hydrochloride
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jul 24, 2017
Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome Trial (fluorouracil, irinotecan HCl, leucovorin calcium)
Completed
- Gastrointestinal Carcinoid Tumor
- +2 more
- fluorouracil
- +2 more
- (no location specified)
May 27, 2016
Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome Trial in United States (AMG 706, octreotide)
Completed
- Gastrointestinal Carcinoid Tumor
- +2 more
- AMG 706
- octreotide
-
Berwyn, Illinois
- +111 more
Jul 12, 2016
Pancreatic Tumor, Pituitary Tumor, Nelson Syndrome Trial in Worldwide (pasireotide LAR)
Terminated
- Pancreatic Neoplasm
- +3 more
- pasireotide LAR
-
Los Angeles, California
- +41 more
Jun 15, 2016
Gastrointestinal Carcinoid Tumor, Islet Cell Carcinoma Trial (octreotide acetate, vatalanib, anti-cytokine therapy)
Withdrawn
- Gastrointestinal Carcinoid Tumor
- Islet Cell Carcinoma
- octreotide acetate
- +10 more
- (no location specified)
Oct 6, 2015
Brain and CNS Tumors, Childhood Langerhans Cell Histiocytosis, Gastrointestinal Carcinoid Tumor Trial in New Haven (indium In
Terminated
- Brain and Central Nervous System Tumors
- +11 more
- indium In 111 pentetreotide
-
New Haven, ConnecticutYale Comprehensive Cancer Center
Jul 1, 2014
Quality of Life in Gastrointestinal-Related Neuroendocrine
Unknown status
- Gastrointestinal Carcinoid Tumor
- +4 more
- questionnaire administration
- quality-of-life assessment
-
Aarhus, Denmark
- +15 more
Oct 28, 2013
Cancer Trial run by the (isolated perfusion, melphalan)
Completed
- Cancer
- isolated perfusion
- melphalan
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Oct 22, 2013
Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Lung Cancer Trial in New York (thalidomide)
Completed
- Gastrointestinal Carcinoid Tumor
- +3 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 17, 2013
Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,
Completed
- Advanced Adult Primary Liver Cancer
- +126 more
- recombinant interleukin-12
- ABI-007/carboplatin/trastuzumab
-
Columbus, OhioOhio State University Medical Center
Feb 27, 2013
Gastrointestinal Carcinoid Tumor, Islet Cell Tumor Trial in United Kingdom (drug, genetic, other)
Completed
- Gastrointestinal Carcinoid Tumor
- Islet Cell Tumor
- capecitabine
- +7 more
-
Basildon, England, United Kingdom
- +16 more
Aug 6, 2013
Cancer Trial in Chandler (Fentanyl sublingual spray, Placebo)
Completed
- Cancer
- Fentanyl sublingual spray
- Placebo
-
Chandler, ArizonaInSys Therapeutics, Incorporated
Jan 14, 2014